Pernix Therapeutics Holdings, Inc.
(NASDAQ : PTX)

( )
PTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
0.49%14.4214.2%$227.85m
SHPGShire PLC Sponsored ADR
-0.22%142.840.4%$213.78m
PRGOPerrigo Co. Plc
-1.49%77.436.4%$150.76m
MNKMallinckrodt Plc
0.22%37.2017.7%$117.37m
UTHRUnited Therapeutics Corporation
-0.43%130.7213.9%$87.52m
JAZZJazz Pharmaceuticals Plc
-0.16%146.502.2%$80.04m
ENDPEndo International Plc
-0.48%8.348.9%$70.27m
HZNPHorizon Pharma plc
-1.45%12.937.6%$64.54m
ALRAlere Inc.
-0.35%49.392.7%$63.82m
PRXLPAREXEL International Corporation
-0.08%87.667.9%$62.65m
ICPTIntercept Pharmaceuticals, Inc.
-0.14%106.9422.1%$62.05m
MYOKMyoKardia, Inc.
0.80%44.153.0%$54.03m
MDCOMedicines Company
1.92%36.0922.3%$43.38m
PTLAPortola Pharmaceuticals, Inc.
0.59%56.288.9%$42.36m
ICLRICON Plc
-1.03%106.784.2%$41.60m

Company Profile

Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. The company's products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products under the following brands: Treximet, Silenor, Zohydro ER with BeadTek, and Khedezla. The company was founded on March 9, 2010 and is headquartered in The Woodlands, TX.